G protein

G protein. G proteins are a family of guanine nucleotide-binding proteins that act as molecular switches inside cells, transmitting signals from a wide variety of stimuli outside the cell to its interior. They are primarily known for their role in transducing signals from the large family of G protein-coupled receptors (GPCRs) located in the plasma membrane. Their activity is regulated by factors that control their ability to bind and hydrolyze GTP, cycling between active and inactive states to control downstream cellular signaling pathways.

Structure and classification

G proteins are heterotrimeric, composed of three distinct subunits: alpha (α), beta (β), and gamma (γ). The Gα subunit binds GDP or GTP and possesses intrinsic GTPase activity. The Gβ and Gγ subunits form a tight, irreversible dimer. Based on sequence and functional homology of the Gα subunit, heterotrimeric G proteins are grouped into four main families: G_s, G_i/o, G_q/11, and G_12/13. The discovery and characterization of these proteins were advanced by the work of Alfred G. Gilman and Martin Rodbell, who were awarded the Nobel Prize in Physiology or Medicine in 1994. Structural studies, often using techniques like X-ray crystallography, have revealed detailed conformations of these proteins in different nucleotide-bound states.

Function and mechanism

In their inactive state, the heterotrimer is bound to GDP and associated with a G protein-coupled receptor. Upon receptor activation by an external ligand, such as a hormone or neurotransmitter, a conformational change promotes the exchange of GDP for GTP on the Gα subunit. This causes the dissociation of the GTP-bound Gα from the Gβγ dimer; both components can then regulate various effector proteins. Key effectors include Adenylyl cyclase, which produces the second messenger cAMP, and Phospholipase C, which generates Inositol trisphosphate and Diacylglycerol. The signal is terminated when the Gα subunit hydrolyzes GTP to GDP, leading to reassociation with Gβγ and the receptor.

G protein-coupled receptors

G proteins are the primary signal transducers for the vast superfamily of G protein-coupled receptors, which are also known as 7TM receptors due to their seven transmembrane helices. GPCRs are targets for a significant proportion of modern medicinal drugs. Notable receptors in this family include the Beta-2 adrenergic receptor, the Rhodopsin receptor in the retina, and receptors for Histamine and Serotonin. The study of GPCR signaling has been profoundly influenced by research at institutions like Duke University and the University of Cambridge. The Protein Data Bank archives numerous high-resolution structures of these receptors in complex with G proteins.

Role in disease

Dysregulation of G protein signaling is a fundamental mechanism in many pathologies. Gain-of-function mutations in Gα subunits, such as in GNAS (encoding G_sα), can lead to McCune-Albright syndrome and certain endocrine tumors. Conversely, loss-of-function mutations are implicated in disorders like Albright's hereditary osteodystrophy. Pertussis toxin, produced by Bordetella pertussis, causes Whooping cough by ADP-ribosylating G_i proteins, disrupting their function. Aberrant G protein signaling is also heavily involved in cardiovascular diseases, psychiatric disorders, and metabolic diseases.

Research and therapeutic applications

G proteins and their associated pathways are major targets for pharmaceutical intervention. Many existing drugs, such as beta-blockers and antihistamines, function by modulating GPCR activity. Current research focuses on developing biased ligands that selectively activate beneficial signaling pathways while avoiding those linked to side effects. Techniques like Cryo-electron microscopy are revolutionizing the understanding of GPCR-G protein complexes. Organizations like the National Institutes of Health and pharmaceutical companies such as Pfizer invest heavily in this area. Furthermore, tools like Optogenetics allow precise control of G protein signaling in research, holding promise for novel therapies for neurological and sensory diseases. Category:Proteins Category:Cell signaling